Detalles de la búsqueda
1.
Severe acute respiratory syndrome (SARS): imaging findings during the acute and recovery phases of disease.
J Thorac Imaging
; 18(3): 195-9, 2003 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-12867818
2.
Providing optimal radiology service in the severe acute respiratory syndrome outbreak: use of mobile CT.
AJR Am J Roentgenol
; 182(1): 57-60, 2004 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-14684512
3.
Methylcellulose as a rectal contrast agent for MR imaging of rectal carcinoma.
AJR Am J Roentgenol
; 178(5): 1145-6, 2002 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-11959719
4.
CT and picture archiving and communication systems: Radiology response to the SARS outbreak.
Radiology
; 228(3): 901, 2003 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-12954906
5.
The effect of Omicron breakthrough infection and extended BNT162b2 booster dosing on neutralization breadth against SARS-CoV-2 variants of concern
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-22278160
6.
Concordance of B and T cell responses to SARS-CoV-2 infection, irrespective of symptoms suggestive of COVID-19.
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-22270393
7.
Humoral responses following SARS-CoV-2 breakthrough infection in COVID-19 vaccinated individuals
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21266982
8.
ADNKA overcomes SARS-CoV2-mediated NK cell inhibition through non-spike antibodies
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-438630
9.
The impact of Spike mutations on SARS-CoV-2 neutralization
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-426849
10.
Single dose of BNT162b2 mRNA vaccine against SARS-CoV-2 induces high frequency of neutralising antibody and polyfunctional T-cell responses in patients with myeloproliferative neoplasms
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21256096
11.
Single dose of BNT162b2 mRNA vaccine against SARS-CoV2 induces neutralizing antibody and polyfunctional T-cell responses in patients with CML
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21255482
12.
Clinical utility of targeted SARS-CoV-2 serology testing to aid the diagnosis and management of suspected missed, late or post-COVID-19 infection syndromes: results from a pilot service
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20150540
13.
Antibody longevity and cross-neutralizing activity following SARS-CoV-2 wave 1 and B.1.1.7 infections
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21258351
14.
Estimates of the rate of infection and asymptomatic COVID-19 disease in a population sample from SE England
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20162701
15.
Comparative assessment of multiple COVID-19 serological technologies supports continued evaluation of point-of-care lateral flow assays in hospital and community healthcare settings
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20120345
16.
Interim results of the safety and immune-efficacy of 1 versus 2 doses of COVID-19 vaccine BNT162b2 for cancer patients in the context of the UK vaccine priority guidelines
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21253131
17.
SARS-CoV-2 recruits a haem metabolite to evade antibody immunity
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21249203
18.
Longitudinal evaluation and decline of antibody responses in SARS-CoV-2 infection
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20148429
19.
A consensus Covid-19 immune signature combines immuno-protection with discrete sepsis-like traits associated with poor prognosis
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20125112
Resultados
1 -
19
de 19
1
Próxima >
>>